Cargando…

Evolutionary ecology of Chagas disease; what do we know and what do we need?

The aetiological agent of Chagas disease, Trypanosoma cruzi, is a key human pathogen afflicting most populations of Latin America. This vectorborne parasite is transmitted by haematophageous triatomines, whose control by large‐scale insecticide spraying has been the main strategy to limit the impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flores‐Ferrer, Alheli, Marcou, Olivier, Waleckx, Etienne, Dumonteil, Eric, Gourbière, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Review and Syntheses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891055/ https://www.ncbi.nlm.nih.gov/pubmed/29636800 http://dx.doi.org/10.1111/eva.12582

Ejemplares similares

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Trypanosoma cruzi transmission dynamics in a synanthropic and domesticated host community
por: Flores-Ferrer, Alheli, et al.
Publicado: (2019)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Intrusive versus domiciliated triatomines and the challenge of adapting vector control practices against Chagas disease
por: Waleckx, Etienne, et al.
Publicado: (2015)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Veteran homelessness in Australia: What do we know? What has been done? What do we need to do?
por: Wallace, Duncan, et al.
Publicado: (2023)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Targeting the Gut Microbiota in Chagas Disease: What Do We Know so Far?
por: Duarte-Silva, Eduardo, et al.
Publicado: (2020)

“What We Know and What We Do Not Know about Evolutionary Genetic Adaptation to High Altitude Hypoxia in Andean Aymaras”
por: Amaru, Ricardo, et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

Mental health among clinicians: what do we know and what can we do?
por: Patel, Mittal, et al.
Publicado: (2021)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

Assessing the risk of West Nile Virus seasonal outbreaks and its vector control in an urbanizing bird community: An integrative R(0)-modelling study in the city of Merida, Mexico
por: Flores-Ferrer, Alheli, et al.
Publicado: (2023)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not
por: Argirò, Alessia, et al.
Publicado: (2022)

Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023)

Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
por: Askenazi, David J., et al.
Publicado: (2009)

Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?
por: Abdulameer, Shaymaa Abdalwahed, et al.
Publicado: (2012)

Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jsfc93c1l8aus5kgvshq7e3omg